Trials / Sponsors / Mark Stein
Mark Stein
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer Recurrent Prostate Cancer | Phase 1 | 2021-08-12 |
| Recruiting | CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition Kidney Cancer, Renal Cell Carcinoma | Phase 2 | 2020-06-22 |
| Active Not Recruiting | REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer Prostate Cancer Metastatic | Phase 2 | 2019-05-16 |
| Active Not Recruiting | Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) Prostate Cancer, Adenocarcinoma of the Prostate | Phase 1 / Phase 2 | 2018-10-11 |